Jeffrey I Bennett MD LFAPA (He/Him)
Associate Professor, Donnelly Family Endowed Professor for Developmental Disabilities
Join to view full profile
319 East Madison StreetSpringfield, IL 62701
Phone+1 217-545-8229
Fax+1 217-545-2275
Dr. Bennett is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jeffrey Bennett is a psychiatrist based in Springfield, IL, with a background in Internal Medicine and Psychiatry from the University of Chicago and an MD from New York University School of Medicine. He serves as an Attending Physician at Decatur Memorial Hospital and Springfield Memorial Hospital and is the Department Chairman at HSHS St. John's Hospital. Dr. Bennett has expertise in electroconvulsive therapy, transcranial magnetic stimulation, vagus nerve stimulation, and intranasal esketamine. His publications cover various aspects of treatment-resistant major depression and psychosocial programs in psychiatric disorders. Dr. Bennett is involved in clinical trials such as the RECOVER sub-study and research on VNS Therapy® System for treatment-resistant depression.
Education & Training
University of ChicagoMD, Neuropsychiatry , 1991 - 1992
University of ChicagoResidency, Psychiatry, 1988 - 1991- University of ChicagoInternship, Internal Medicine, 1987 - 1988
New York University School of MedicineClass of 1986
Certifications & Licensure
IL State Medical License 1990 - 2029
American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression Start of enrollment: 2019 Sep 26
- The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes Start of enrollment: 2021 Mar 23
Publications & Presentations
PubMed
- 2 citationsDurability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report.Charles R Conway, Augustus John Rush, Scott T Aaronson, Mark T Bunker, Charles Gordon
The International Journal of Neuropsychopharmacology. 2026-01-06 - 12 citationsEffects of vagus nerve stimulation on daily function and quality of life in markedly treatment-resistant major depression: Findings from a one-year, randomized, sham-c...A John Rush, Charles R Conway, Scott T Aaronson, Mark S George, Patricio Riva-Posse
Brain Stimulation. 2024-12-18 - 4 citationsIncreasing Abnormal Involuntary Movement Scale (AIMS) Screening for Tardive Dyskinesia in an Outpatient Psychiatry Clinic: A Resident-Led Outpatient Lean Six Sigma Ini...Arindam C Chakrabarty, Jeffrey I Bennett, Talha J Baloch, Rohit P Shah, Cassie Hawk
Cureus. 2023-05-01
Press Mentions
Dr. Jeffrey Bennett: Mental Health AwarenessAugust 12th, 2017
Committees
- Member, APA Membership Committee 2016 - 2022
Professional Memberships
- Member
- Member
- American Society for Clinical PsychopharmacologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
